Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S B (OP:NONOF)

70.98 +1.78 (+2.57%)
Streaming Delayed Price Updated: 3:52 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,190
Open 71.75
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 69.20
Today's Range 68.50 - 71.75
52wk Range 55.28 - 149.55
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms. 
Via Benzinga
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide. 
Via Benzinga

Performance

YTD
-18.5%
-18.5%
1 Month
+16.1%
+16.1%
3 Month
-21.6%
-21.6%
6 Month
-32.1%
-32.1%
1 Year
-47.9%
-47.9%

More News

Read More
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Via InvestorPlace
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
Via Benzinga
7 Mutual Funds That Will Outperform in Any Market
Via InvestorPlace
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
Via Benzinga
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
Via Benzinga
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
Via Benzinga
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
Via Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
Via Benzinga

Frequently Asked Questions

Is Novo Nordisk A/S B publicly traded?
Yes, Novo Nordisk A/S B is publicly traded.
What exchange does Novo Nordisk A/S B trade on?
Novo Nordisk A/S B trades on the OTC Traded
What is the ticker symbol for Novo Nordisk A/S B?
The ticker symbol for Novo Nordisk A/S B is NONOF on the OTC Traded
What is the current price of Novo Nordisk A/S B?
The current price of Novo Nordisk A/S B is 70.98
When was Novo Nordisk A/S B last traded?
The last trade of Novo Nordisk A/S B was at 05/30/25 03:52 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.